Phio Other Operating Expenses from 2010 to 2024
| PHIO Stock | USD 0.75 0.03 4.17% |
Other Operating Expenses | First Reported 2011-03-31 | Previous Quarter 2.8 M | Current Value 1.8 M | Quarterly Volatility 962.2 K |
Check Phio Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phio Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 115.8 K, Interest Expense of 211.3 K or Other Operating Expenses of 9 M, as well as many indicators such as Price To Sales Ratio of 275, Dividend Yield of 0.0 or PTB Ratio of 0.19. Phio financial statements analysis is a perfect complement when working with Phio Pharmaceuticals Valuation or Volatility modules.
Phio | Other Operating Expenses |
Latest Phio Pharmaceuticals' Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Phio Pharmaceuticals Corp over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Phio Pharmaceuticals Corp. It is also known as Phio Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Phio Pharmaceuticals' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phio Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Phio Other Operating Expenses Regression Statistics
| Arithmetic Mean | 11,165,736 | |
| Geometric Mean | 10,786,165 | |
| Coefficient Of Variation | 30.32 | |
| Mean Deviation | 2,391,811 | |
| Median | 10,271,000 | |
| Standard Deviation | 3,385,662 | |
| Sample Variance | 11.5T | |
| Range | 13.8M | |
| R-Value | (0.39) | |
| Mean Square Error | 10.5T | |
| R-Squared | 0.15 | |
| Significance | 0.15 | |
| Slope | (295,738) | |
| Total Sum of Squares | 160.5T |
Phio Other Operating Expenses History
About Phio Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Phio Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Phio Pharmaceuticals investors use historical funamental indicators, such as Phio Pharmaceuticals's Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Phio Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Phio Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Phio Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Phio Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Phio Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 10.7 M | 9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Phio Stock
When determining whether Phio Pharmaceuticals Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phio Pharmaceuticals Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phio Pharmaceuticals Corp Stock:Check out the analysis of Phio Pharmaceuticals Correlation against competitors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.52) | Return On Assets (0.70) | Return On Equity (1.45) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.